Deutsche Bank’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$797K	Sell	54,479 -1,560	-3%	-$24.9K	﹤0.01%	2317
2025 Q4	$432K	Buy	56,039 +2,400	+4%	+$18.9K	﹤0.01%	2654
2025 Q3	$395K	Buy	53,639 +9,651	+22%	+$49.4K	﹤0.01%	2677
2025 Q2	$176K	Buy	+43,988	New	+$160K	﹤0.01%	3031
2019 Q4	–	Sell	-337	Closed	-$1K	–	5001
2019 Q3	$1K	Sell	337 -118,299	-100%	-$496K	﹤0.01%	4803
2019 Q2	$442K	Sell	118,636 -69,414	-37%	-$272K	﹤0.01%	3350
2019 Q1	$754K	Sell	188,050 -19,732	-9%	-$83.3K	﹤0.01%	3176
2018 Q4	$762K	Buy	207,782 +148,493	+250%	+$1.01M	﹤0.01%	3059
2018 Q3	$509K	Buy	59,289 +24,636	+71%	+$246K	﹤0.01%	3772
2018 Q2	$381K	Sell	34,653 -80,915	-70%	-$903K	﹤0.01%	3985
2018 Q1	$1.33M	Buy	115,568 +96,510	+506%	+$913K	﹤0.01%	3135
2017 Q4	$196K	Buy	19,058 +10,320	+118%	+$132K	﹤0.01%	4037
2017 Q3	$138K	Sell	8,738 -1,149	-12%	-$15.9K	﹤0.01%	4046
2017 Q2	$119K	Sell	9,887 -3,233	-25%	-$34.5K	﹤0.01%	4149
2017 Q1	$271K	Buy	13,120 +11,128	+559%	+$174K	﹤0.01%	3421
2016 Q4	$27K	Buy	1,992 +1,444	+264%	+$22K	﹤0.01%	4524
2016 Q3	$9K	Sell	548 -2,912	-84%	-$42K	﹤0.01%	4682
2016 Q2	$49K	Buy	+3,460	New	+$46.7K	﹤0.01%	4421